MEGAINPHARM GMBH has a total of 17 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals are TRADITIONAL CHINESE MEDICINE I, APBI HOLDINGS LLC and BIOLOG I I SISTEMY AOZT.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Republic of Korea | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Germany | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Moldova | 1 | |
#12 | Mexico | 1 | |
#13 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Rudko Adolina | 9 |
#2 | Rudko Adolina Petrovna | 3 |
#3 | Krivoshein Yuru Semionovich | 2 |
#4 | Petrovna Rudko Adolina | 1 |
#5 | Rudko Adolina A | 1 |
#6 | Adolina Rudko | 1 |
#7 | Rudko Alolina Petrovna | 1 |
#8 | Yuru Krivoshein | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011100994A1 | Pharmaceutical comprising myramistin | |
DE102008039254A1 | Medicament, useful e.g. for treating infectious- and purulent inflammatory diseases of e.g. eyes, comprises benzyl-dimethyl-(3-(myristoylamino)-propyl)-ammonium chloride, dimethyl-(3-(myristoylamino)-propyl)-amine oxide and solvent | |
EP1634590A1 | Coronavirus inactivating agent |